<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionVersion>
        <isActive>true</isActive>
        <name>Sebelipase_Alfa_Renewal_Discountinuation_Criteria_Q2</name>
        <optionSourceResponseValue>false</optionSourceResponseValue>
        <questionText>Is the patient experiencing any adverse events (particularly hypersensitivity reactions, anaphylaxis, hypotension,
fever) from treatment with sebelipase alfa which cannot be managed with standard treatment and/or have a
significant impact on the patientâ€™s quality of life, or are life-threatening?</questionText>
        <responseValues>Yes
No</responseValues>
        <status>Active</status>
        <versionNumber>1</versionNumber>
    </assessmentQuestionVersion>
    <dataType>Radio</dataType>
    <developerName>Sebelipase_Alfa_Renewal_Discountinuation_Criteria_Q2</developerName>
    <name>Sebelipase_Alfa_Renewal_Discountinuation_Criteria_Q2</name>
    <questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
